Pathway TSXV Life Sciences Conference Feedback Listened to the company present today - the presentation was great and everything seems to be going pretty well. It is quite unclear to me why the stock isn't trading well when the value seems so reasonable.
My hypothesis is that the company is not press releasing enough and thus doesn't have a captive audience. This isn't necessarily a bad thing (at least not a pump and dump press releasing fluff), but I do believe they need a much better IR strategy.
They also need more intiatives like the conference today - get in front of people and get the story out there. I'm considering increasing position size given relative weakness since RTO.